Login or sign up
For business
Average ratingGreat
4.1/ 5

Based on 9 reviews

544%
422%
333%
20%
10%
Ask AI

What reviewers say about Synthena

Generated with AI from 9 reviews on Trustburn · updated 64 days ago

Customers generally describe positive experiences with Synthena, frequently praising product quality, responsive customer service, easy-to-use website, reasonable prices, and fast delivery, and most reviewers say they would recommend the company.
What does Synthena do?

Synthena is a development stage biotechnology company aiming to develop and commercialize new life saving drugs for the treatment of severe neuromuscular diseases based on the modulation of RNA, using its proprietary tricyclo-DNA technology platform.

What are the most common complaints about Synthena?

There are no common complaints mentioned in the reviews on file; reviewers consistently describe positive experiences with product quality, customer service, website usability, and delivery.

AI-generated from reviews on this page. Verify anything important with the company directly.

John Stiles
Reviews 1

Synthena is a reliable company with excellent customer service. I have been using their products for a while now and I am very satisfied with the quality and performance. The website is user-friendly and easy to navigate. The team is always ready to assist and answer any questions. I highly recommend Synthena!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Synthena

Synthena is a development stage biotechnology company aiming to develop and commercialize new life saving drugs for the treatment of severe neuromuscular diseases based on the modulation of RNA. Its proprietary tricyclo-DNA technology platform offers broad advantages over state of the art oligonucleotide chemistries for new RNA intervention strategies like splice switching, and other antisense approaches. Its most advanced preclinical drug development program focuses on Duchenne Muscular Dystrophy, a genetic disorder which affects 1/3,500 boys and which leads to death in early adulthood.